PRIME GRANT

U24NS113844

Cooperative Agreement

Overview

Awardee
New York University
Grant Description
EPPIC-NET DCC
Grant Program (CFDA)
93.279 - Drug Abuse and Addiction Research Programs
Awarding / Funding Agency
National Institute of Neurological Disorders and Stroke (NNDS) [HHS - NIH]
Place of Performance
New York United States
Geographic Scope
State-Wide
Related Opportunity
HEAL Initiative: Early Phase Pain Investigation Clinical Network - Data Coordinating Center (U24 Clinical Trials Not Allowed) (RFA-NS-19-024)
Notes
Amendment Since initial award the total obligations have increased 65% from $13,303,854 to $21,962,168.
New York University was awarded EPPIC-NET DCC Cooperative Agreement U24NS113844 worth $21,962,168 from the National Institute of Neurological Disorders and Stroke in September 2019. The grant has a duration of 5 years and was awarded through assistance program 93.279 Drug Abuse and Addiction Research Programs.

Status
(Ongoing)

Last Modified 9/20/23

Period of Performance
9/30/19
Start Date
8/31/24
End Date
81.0% Complete

Funding Split
$22.0M
Federal Obligation
$0.0
Non-Federal Obligation
$22.0M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Transaction History

Modifications to U24NS113844

Additional Detail

Award ID FAIN
U24NS113844
SAI Number
U24NS113844-2738624820
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NQ00 NIH NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Funding Office
75NQ00 NIH NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Performance District
NY-NY-12
Senators
Kirsten Gillibrand
Charles Schumer
Modified: 9/20/23